Calendar Cumberland Pharmaceuticals Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:30:00 26/04/2024 BST			5-day change	1st Jan Change
1.76 ^USD	+3.53%		+10.00%	-1.77%

03-13	Tranche Update on Cumberland Pharmaceuticals Inc.'s Equity Buyback Plan announced on May 13, 2010.	CI
03-05	Cumberland Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

630b0d6d7.qCfyQPteFupYSkbDyQSiEUfG4XhrkhErhDOoKwsc5Wc.4mymEqsHULMVHhmX5HDQJBakoBAm5Udg4h7tEz9Y1SDOfZMlnGcn32AmFw~6b1eb0ee2585719e7dc048a3d38cae83

06/05/2024	Q1 2024 Earnings Release (Projected)
05/08/2024	Q2 2024 Earnings Release (Projected)
04/11/2024	Q3 2024 Earnings Release (Projected)
10/03/2025	Q4 2024 Earnings Release (Projected)

22/04/2024	Annual General Meeting
05/03/2024 21:30	Q4 2023 Earnings Call
05/03/2024 21:05	Q4 2023 Earnings Release
07/11/2023 21:30	Q3 2023 Earnings Call
07/11/2023 21:05	Q3 2023 Earnings Release
08/08/2023 21:30	Q2 2023 Earnings Call
08/08/2023 21:05	Q2 2023 Earnings Release
09/05/2023 21:30	Q1 2023 Earnings Call
09/05/2023 21:05	Q1 2023 Earnings Release
25/04/2023 15:30	Annual General Meeting
07/03/2023 21:30	Q4 2022 Earnings Call
07/03/2023 21:23	Q4 2022 Earnings Release
08/11/2022 21:30	Q3 2022 Earnings Call
07/11/2022	Q3 2022 Earnings Release After hours
09/08/2022 21:30	Interim 2022 Earnings Call
09/08/2022 21:05	Interim 2022 Earnings Release
10/05/2022 21:30	Q1 2022 Earnings Call
10/05/2022 21:05	Q1 2022 Earnings Release
28/04/2022 15:30	Annual General Meeting
08/03/2022 21:30	FY 2021 Earnings Call

Fiscal Period	December	2019	2020
Net sales Million USD	Released Forecast Spread	47,5 45,2 5.17%	37,4 37,0 1.19%
EBITDA Million USD	Released Forecast Spread	4,98 3,65 36.5%	-0,07 -0,39 82.62%
EBIT Million USD	Released Forecast Spread	-3,62 -4,89 25.92%	-6,38 -6,31 -1.18%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-3,63 -4,88 25.65%	-6,57 -6,53 -0.66%
Net income Million USD	Released Forecast Spread	-3,54 -4,79 26.2%	-3,34 -3,42 2.47%
EPS USD	Released Forecast Spread	-0,23 -0,31 25.81%	-0,22 -0,22 0%
Announcement Date		18/03/20	09/03/21

28/04/2024	CHONGQING PHARSCIN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024	SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.: Q1 2024 Earnings Release
29/04/2024	SINOTHERAPEUTICS INC.: Q4 2023 Earnings Release
29/04/2024	KUNMING LONGJIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
29/04/2024	OTSUKA HOLDINGS CO., LTD.: Q1 2024 Earnings Release
29/04/2024	YIFAN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024	HANMI PHARM. CO., LTD.: Q1 2024 Earnings Release
01/05/2024	AJANTA PHARMA LIMITED: Q4 2024 Earnings Release (Projected)
01/05/2024	PROCTER & GAMBLE HEALTH LIMITED: Q3 2024 Earnings Release (Projected)
06/05/2024	SANDOZ GROUP AG: Q1 2024 Sales and Revenue Release

Today	HYBIO PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today	APICHOPE PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
Today	YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.: Q1 2024 Earnings Release
Today	HARBIN GLORIA PHARMACEUTICALS CO., LTD: Q1 2024 Earnings Release
Today	SHANGHAI HAIXIN GROUP CO., LTD.: Q1 2024 Earnings Release
Today	ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
Today	YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.: Q4 2023 Earnings Release
Today	HYBIO PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
25/04/2024	SINOTHERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
25/04/2024	SICHUAN GOLDSTONE ASIA PHARMACEUTICAL INC.: Q1 2024 Earnings Release